Avenue Therapeutics, Inc. (OTC: ATXI), a Fortress Biotech (NASDAQ: FBIO) subsidiary, is a specialty pharmaceutical company focused on the development and commercialization of therapies for rare and neurologic diseases. Please be aware of Recruiting Fraud: https://www.avenuetx.com/beware-of-recruiting-fraud/
Looking for a particular Avenue Therapeutics employee's phone or email?
The Avenue Therapeutics annual revenue was $1 million in 2026.
Alexandra MacLean is the Chief Executive Officer and Member Board of Directors of Avenue Therapeutics.
7 people are employed at Avenue Therapeutics.
Avenue Therapeutics is based in Bay Harbor Islands, Florida.
The NAICS codes for Avenue Therapeutics are [3254, 32, 325, 32541, 54, 541].
The SIC codes for Avenue Therapeutics are [28, 87, 283, 873].